Symptoms and medication management in the end of life phase of high-grade glioma patients

Journal of Neuro-Oncology

Volumn 120, Issue 3, 2014, Pages 589-595

  Koekkoek, J A F ^a,b   Dirven, L ^a   Sizoo, E M ^a   Pasman, H R W ^a   Heimans, J J ^a   Postma, T J ^a   Deliens, L ^a,c   Grant, R ^d   McNamara, S ^d   Stockhammer, G ^e   Medicus, E ^f   Taphoorn, M J B ^a,b   Reijneveld, J C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f Hospice and Palliative Care Unit Tyrolean Hospice Community   (Austria)

Author keywords

Antiepileptic drugs; Brain tumor; End of life care; Glioma; Medication therapy management; Palliative care; Signs and symptoms

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DYSPHAGIA; FEMALE; GLIOMA; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; NEUROLOGIC DISEASE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SOMNOLENCE; TERMINAL CARE; BRAIN NEOPLASMS; CANCER GRADING; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTION; PROCEDURES;

BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PERCEPTION; PREVALENCE; QUALITY OF HEALTH CARE; QUESTIONNAIRES; TERMINAL CARE;

EID: 84911400434     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1591-2     Document Type: Article

References (40)

1. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J et al (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48(10):1532–1542
2. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre JY (2012) Primary brain tumours in adults. Lancet 379(9830):1984–1996
3. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507
4. Pace A, Metro G, Fabi A (2010) Supportive care in neurooncology. Curr Opin Oncol 22(6):621–626
5. Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G et al (2014) The end-of-life phase of high-grade glioma patients: a systematic review. Support Care Cancer 22(3):847–857
6. Walbert T, Khan M (2014) End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol 117(2):217–224
7. Heimans JJ, Taphoorn MJ (2002) Impact of brain tumour treatment on quality of life. J Neurol 249(8):955–960
8. Janda M, Steginga S, Langbecker D, Dunn J, Walker D, Eakin E (2007) Quality of life among patients with a brain tumor and their carers. J Psychosom Res 63(6):617–623
9. Sizoo EM, Braam L, Postma TJ, Pasman HR, Heimans JJ, Klein M et al (2010) Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol 12(11):1162–1166
10. Bausewein C, Hau P, Borasio GD, Voltz R (2003) How do patients with primary brain tumours die? Palliat Med 17(6):558–559
11. Sizoo EM, Taphoorn MJ, Uitdehaag B, Heimans JJ, Deliens L, Reijneveld JC et al (2013) The end-of-life phase of high-grade glioma patients: dying with dignity? Oncologist 18(2):198–203
12. Pace A, Di LC, Guariglia L, Jandolo B, Carapella CM, Pompili A (2009) End of life issues in brain tumor patients. J Neurooncol 91(1):39–43
13. Oberndorfer S, Lindeck-Pozza E, Lahrmann H, Struhal W, Hitzenberger P, Grisold W (2008) The end-of-life hospital setting in patients with glioblastoma. J Palliat Med 11(1):26–30
14. Ostgathe C, Gaertner J, Kotterba M, Klein S, Lindena G, Nauck F et al (2010) Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 18(9):1157–1163
15. Faithfull S, Cook K, Lucas C (2005) Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided. Palliat Med 19(7):545–550
16. Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ, et al. (2014) End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol
17. Sizoo EM, Pasman HR, Buttolo J, Heimans JJ, Klein M, Deliens L et al (2012) Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer 48(2):226–232
18. Sizoo EM, Dirven L, Reijneveld JC, Postma TJ, Heimans JJ, Deliens L et al (2014) Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire. J Neurooncol 116(2):283–290
19. Liu Y, Zhang PY, Na J, Ma C, Huo WL, Han L et al (2013) Prevalence, intensity, and prognostic significance of common symptoms in terminally ill cancer patients. J Palliat Med 16(7):752–757
20. Ruijs CD, Kerkhof AJ, van der Wal G, Onwuteaka-Philipsen BD (2013) Symptoms, unbearability and the nature of suffering in terminal cancer patients dying at home: a prospective primary care study. BMC Fam Pract 14:201
21. Costantini M, Ripamonti C, Beccaro M, Montella M, Borgia P, Casella C et al (2009) Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients’ life. Results of an Italian mortality follow-back survey. Ann Oncol 20(4):729–735
22. Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17(4):310–314
23. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361(9354):323–331
24. Steigleder T, Stiel S, Ostgathe C (2013) Dying of brain tumours: specific aspects of care. Curr Opin Support Palliat Care 7(4):417–423
25. Lo C, Zimmermann C, Rydall A, Walsh A, Jones JM, Moore MJ et al (2010) Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol 28(18):3084–3089
26. Ruijs CD, Kerkhof AJ, van der Wal G, Onwuteaka-Philipsen BD (2011) Depression and explicit requests for euthanasia in end-of-life cancer patients in primary care in the Netherlands: a longitudinal, prospective study. Fam Pract 28(4):393–399
27. De Korte-Verhoef MC, Pasman HR, Schweitzer BP, Francke AL, Onwuteaka-Philipsen BD, Deliens L (2014) Reasons for hospitalisation at the end of life: differences between cancer and non-cancer patients. Support Care Cancer 22(3):645–652
28. Hall P, Schroder C, Weaver L (2002) The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc 50(3):501–506
29. Liu Y, Zhang PY, Na J, Ma C, Huo WL, Han L et al (2013) Prevalence, intensity, and prognostic significance of common symptoms in terminally ill cancer patients. J Palliat Med 16(7):752–757
30. Gagnon P, Allard P, Gagnon B, Merette C, Tardif F (2012) Delirium prevention in terminal cancer: assessment of a multicomponent intervention. Psychooncology 21(2):187–194
31. Pace A, Villani V, Di LC, Guariglia L, Maschio M, Pompili A et al (2013) Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neurooncol 111(1):83–86
32. Sizoo EM, Koekkoek JA, Postma TJ, Heimans JJ, Pasman HR, Deliens L et al (2014) Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase. BMJ Support Palliat Care 4(1):77–80
33. Krouwer HG, Pallagi JL, Graves NM (2000) Management of seizures in brain tumor patients at the end of life. J Palliat Med 3(4):465–475
34. Raijmakers NJ, van Zuylen L, Furst CJ, Beccaro M, Maiorana L, Pilastri P et al (2013) Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer 21(4):1003–1011
35. Lindqvist O, Lundquist G, Dickman A, Bukki J, Lunder U, Hagelin CL et al (2013) Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med 16(1):38–43
36. Pisani F, Oteri G, Costa C, Di RG, Di PR (2002) Effects of psychotropic drugs on seizure threshold. Drug Saf 25(2):91–110
37. Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10(2):31–38
38. Maltoni M, Scarpi E, Nanni O (2013) Palliative sedation in end-of-life care. Curr Opin Oncol 25(4):360–367
39. Bukki J, Scherbel J, Stiel S, Klein C, Meidenbauer N, Ostgathe C (2013) Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review. Support Care Cancer 21(6):1743–1750
40. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742